TMRW Life Sciences
Max Farina, MD, is a Principal at 5AM Ventures since February 2021, with previous roles as a Senior Associate and Associate at the same firm. Max serves as a Board Observer for several companies, including Karius, Portal Instruments, Skye Bioscience Inc., TMRW Life Sciences, Precede Biosciences, Kinaset Therapeutics, and Scientist.com. Max holds a Doctor of Medicine (MD) from Yale School of Medicine and a Master of Business Administration (MBA) from Yale School of Management. Additionally, Max earned a Bachelor of Science (BS) in Neuroscience and Behavioral Biology, along with a degree in Music Performance from Emory University.
This person is not in any teams
This person is not in any offices
TMRW Life Sciences
1 followers
TMRW safeguards the world’s most precious cells for life. The TMRW platform revolutionizes the management, identification, and storage of fertility cells, replacing the manual and analog methods that have remained largely unchanged since IVF was first used in animal husbandry more than 50 years ago.